| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE | 37 | 0.2403 |
| 1 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 44 | 0.0772 |
| 2 | COAGULATION FACTOR VIIA RECOMBINANT HUMAN | 7 | 0.0753 |
| 3 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI | 3 | 0.0390 |
| 4 | ANTI-INHIBITOR COAGULANT COMPLEX | 30 | 0.0272 |
| 5 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 117 | 0.0141 |
| 6 | ANTIHEMOPHILIC FACTOR HUMAN | 16 | 0.0118 |
| 7 | COAGULATION FACTOR VIIA (RECOMBINANT) | 20 | 0.0074 |
| 8 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | 8 | 0.0048 |
| 9 | ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN) | 4 | 0.0037 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antifibrinolytic Agent [EPC] | 7 | 0.0007 |
| 1 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 2 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 5 | 0.0000 |
| 7 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 3 | 0.0000 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 3 | 0.0000 |